HIGHLIGHTS
- who: Thomas Halverson from the hypothesis Mirabegron, a beta, agonist, is prescribed for urgency urinary incontinence (UUI)We assessed the correlation of symptom improvement with urobiome characteristics in adult women participants prescribed mirabegron for UUI treatment. Methods We enrolled participants seeking UUI treatment who selected mirabegron and agreed to participate in this, week, open label study conducted at the Female Pelvic Medicine and Reconstructive Surgery Center at Loyola University Medical Center. Following eligibility screening and research consent, participants completed the overactive bladder questionnaire (OAB-Q) and provided a catheterized urine sample at baseline, , and , weeks. The primary . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.